← Back to Search

Screening for Cardiovascular Disease Impact by Social Determinants (CVRRC Trial)

N/A
Recruiting
Led By Katherine Sanchez, PhD
Research Sponsored by Baylor Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

CVRRC Trial Summary

This trial looks at how social and economic factors affect heart health in low-income minority groups, suggesting those in poverty and with depression may be at greater risk of heart disease.

Who is the study for?
This trial is for adults over 18 who can read and are part of a low-income, racial, or ethnic minority group. It's especially focused on those at risk for health disparities and may be struggling with depression or have concerns about cardiovascular health.Check my eligibility
What is being tested?
The study is looking into how social factors like income level and mental health status (specifically depression) affect heart and blood vessel health in vulnerable populations.See study design
What are the potential side effects?
Since the intervention involves screening rather than medication or procedures, there aren't direct side effects. However, participants might experience discomfort discussing personal issues during the assessment.

CVRRC Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
AAFP Social Needs Screening Tool
Adverse Childhood Experiences (ACE)
Connor-Davidson Resilience Scale (CD-RISC-10)
+12 more

CVRRC Trial Design

1Treatment groups
Experimental Treatment
Group I: Interviewer-AdministeredExperimental Treatment1 Intervention
Screening assessments to measure social determinants of health in relation to cardiovascular disease.

Find a Location

Who is running the clinical trial?

The University of Texas at ArlingtonOTHER
43 Previous Clinical Trials
4,838 Total Patients Enrolled
Baylor Research InstituteLead Sponsor
200 Previous Clinical Trials
203,321 Total Patients Enrolled
University of Texas-ArlingtonUNKNOWN
4 Previous Clinical Trials
650 Total Patients Enrolled

Media Library

Interviewer-Administered Clinical Trial Eligibility Overview. Trial Name: NCT05772221 — N/A
Social Determinants of Health Research Study Groups: Interviewer-Administered
Social Determinants of Health Clinical Trial 2023: Interviewer-Administered Highlights & Side Effects. Trial Name: NCT05772221 — N/A
Interviewer-Administered 2023 Treatment Timeline for Medical Study. Trial Name: NCT05772221 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research opportunity currently available to participants?

"Correct. Per the information recorded on clinicaltrials.gov, this medical trial is actively searching for participants to join their experiment; it was first posted June 29th 2023 and most recently updated July 25th 2023. The goal is to fill 100 spots at 1 site in total."

Answered by AI

How many participants are allowed to join this research endeavor?

"Affirmative, the data provided by clinicaltrials.gov demonstrates that this medical trial is actively seeking enrolment. The study was initially posted on June 29th 2023 and has been updated most recently on July 25th 2023. This research requires 100 participants from a single location to be recruited."

Answered by AI

Who else is applying?

What site did they apply to?
Baylor Scott & White Family Health Center at Juanita J. Craft Recreation Center
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0
3+

Why did patients apply to this trial?

Opportunity to improve my life for my family and myself.
PatientReceived no prior treatments
~57 spots leftby Apr 2025